Identification of Genotype 2 HCV in Serotype-1 Hepatitis C Patients Unresponsive to Daclatasvir Plus Asunaprevir Treatment

Tohoku Journal of Experimental Medicine - Japan
doi 10.1620/tjem.241.21
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Tohoku University Medical Press

Related search

Hemoglobin Decrease With Iron Deficiency Induced by Daclatasvir Plus Asunaprevir Combination Therapy for Chronic Hepatitis C Virus Genotype 1b

PLoS ONE
Multidisciplinary
2016English

Secondary Occult Hepatitis C Virus Infection (HCV) in Chronic HCV Patients After Treatment With Sofosbuvir and Daclatasvir

International Journal of Current Microbiology and Applied Sciences
2018English

Sofosbuvir Plus Daclatasvir With or Without Ribavirin in 551 Patients With Hepatitis C-Related Cirrhosis, Genotype 4

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2018English

Raltegravir Pharmacokinetics in Patients on Asunaprevir-Daclatasvir: TABLE 1

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2015English

Reliable Resolution of Ambiguous Hepatitis C Virus Genotype 1 Results With the Abbott HCV Genotype Plus RUO Assay

Scientific Reports
Multidisciplinary
2019English

Serum Alpha-Fetoprotein Predicts Treatment Outcome in Chronic Hepatitis C Patients Regardless of HCV Genotype

PLoS ONE
Multidisciplinary
2008English

Changes in Serum LDL, PCSK9 and microRNA‑122 in Patients With Chronic HCV Infection Receiving Daclatasvir/Asunaprevir

Biomedical Reports
GeneticsPharmacologyMolecular BiologyBiochemistryNeuroscienceMedicineToxicologyPharmaceutics
2019English

Pharmacist Intervention in Treatment of Patients With Genotype 1 Chronic Hepatitis C

Journal of Managed Care Pharmacy
2009English

Safety of Ombitasvir/Paritaprevir/Ritonavir+dasabuvir in Chronic Hepatitis C Patients With HCV Genotype 1 Infection

Acta Poloniae Pharmaceutica
PharmacologyPharmaceutical Science
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy